0
Articles   |    
Studies of EN-1639A (Naltrexone): A New Narcotic Antagonist
RICHARD B. RESNICK; JAN VOLAVKA; ALFRED M. FREEDMAN; MURIEL THOMAS
Am J Psychiatry 1974;131:646-650.
View Article Information
Assistant Professor, Department of Psychiatry, New York Medical College, 5 East 102nd St., New York, N.Y. 10029
Associate Professor, Department of Psychiatry, New York Medical College, 5 East 102nd St., New York, N.Y. 10029
Professor and Chairman, Department of Psychiatry, New York Medical College, 5 East 102nd St., New York, N.Y. 10029
Instructor, Department of Psychiatry, New York Medical College, 5 East 102nd St., New York, N.Y. 10029
1974, The American Psychiatric Association
text A A A
PDF of the full text article.
Abstract
The narcotic antagonist EN-1639A (naltrexone) was studied in 37 heroin addicts and found to be clinically useful, with a low incidence of side effects, lack of toxicity, high degree of acceptability to the patient, and capacity to antagonize the euphoric effects of heroin for up to 72 hours after a single oral dose. These findings provide a basis for expanding studies of the clinical efficacy of naltrexone in the treatment of opiate dependence.Abstract Teaser
Figures in this Article

    Your Session has timed out. Please sign back in to continue.
    Sign In Your Session has timed out. Please sign back in to continue.
    Sign In to Access Full Content
     
    Username
    Password
    Sign in via Athens (What is this?)
    Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
    Not a subscriber?

    Subscribe Now/Learn More

    PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

    +
    +
    +

    CME Activity

    There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
    Submit a Comments
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe



    Related Content
    Books
    Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 14.  >
    The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 22.  >
    What Your Patients Need to Know About Psychiatric Medications, 2nd Edition > Chapter 88.  >
    The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 9.  >
    Psychiatric News
    APA Guidelines
    PubMed Articles